protein: 2022g Food: Soft tofu Small GLP-1 portion: 1/2 block Approx
There is evidence that titrating GLP-1 dosage and switching between GLP-1 medications can occur in clinical practice due to factors such as lack of desired impact, patient preference, insurance coverage and side effects
C.AlvarezJ
Finally, Achari reiterated the need for more research in healthy populations rather than extrapolating from existing studies
August 2025 : The US FDA approved Wegovy (semaglutide 2.4 mg) for the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) in adults with moderate to advanced liver fibrosis (consistent with stages F2 to F3 fibrosis), in combination with a reduced-calorie diet and increased physical activity
And overwhelmingly, these drugs have only been available for people who have wealth. (Obesity rates actually are slightly higher for middle-income Americans than they are for those with the lowest and highest incomes, according to 2017-2020 data collected by the US Centers for Disease Control and Prevention.) Kennedy had previously expressed skepticism about GLP-1s, but he was full of praise for Trump for pushing to help a broader segment of Americans have access to the drug